Neuronetics

Contributing Author

Recent Articles by Neuronetics

Jul-31	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) STIM GlobeNewswire
Jul-28	Greenbrook Opens National Center of Excellence for Advanced Interventional Psychiatry in Rockville, Maryland STIM GlobeNewswire
Jul-28	Neuronetics to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call STIM GlobeNewswire
Jul-20	Neuronetics Appoints Nir Naor Chief Financial Officer; Announces Additional Management Changes STIM +24.69% STIM -6.93% GlobeNewswire
Jul-06	Neuronetics to Participate in a Panel Discussion at B. Riley Securities' Mind, Muscle & Vision Summit on July 16, 2026 STIM +10.64% GlobeNewswire
Jun-02	Neuronetics Appoints Robert Greene as Senior Vice President Sales STIM -6.59% STIM -10.90% GlobeNewswire
Jun-02	Neuronetics Highlights Continued Advancements in TMS Research at CTMSS 2026 STIM -6.59% GlobeNewswire
May-14	Neuronetics and ANT Neuro Announce Strategic Collaboration to Integrate Neuronavigation with NeuroStar TMS Treatment STIM -13.91% GlobeNewswire
May-05	Neuronetics Reports First Quarter 2026 Financial and Operating Results STIM +7.43% GlobeNewswire
Apr-29	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) STIM STIM +14.12% GlobeNewswire
Apr-21	Neuronetics to Report First Quarter 2026 Financial and Operating Results and Host Conference Call STIM -5.06% GlobeNewswire
Apr-13	Optum/United Healthcare/United Behavioral Health Expands NeuroStar TMS Coverage to Include Psychiatric Mental Health Nurse Practitioners STIM GlobeNewswire
Apr-07	Neuronetics Comments on Letter from Pointillist Family Office STIM -10.23% GlobeNewswire
Apr-06	Neuronetics Announces Chief Financial Officer Transition STIM +15.79% GlobeNewswire
Mar-17	Neuronetics Reports Fourth Quarter and Full Year 2025 Financial and Operating Results STIM -9.93% GlobeNewswire
Mar-17	Neuronetics Appoints Dan Reuvers as President and Chief Executive Officer STIM -9.93% GlobeNewswire
Mar-03	Neuronetics to Report Fourth Quarter 2025 Financial and Operating Results and Host Conference Call STIM GlobeNewswire
Feb-10	Neuronetics Announces Selected Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial Results STIM STIM +23.29% GlobeNewswire
Nov-20	Neuronetics to Participate at the Piper Sandler 37th Annual Healthcare Conference STIM -12.75% GlobeNewswire
Nov-12	TRICARE West Expands NeuroStar TMS Coverage to Include Adolescents Aged 15+ Struggling with Depression STIM GlobeNewswire
Nov-04	Neuronetics Reports Third Quarter 2025 Financial and Operating Results and Announces CEO Transition Plan STIM GlobeNewswire
Oct-31	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) STIM GlobeNewswire
Oct-30	Neuronetics Announces Three-Year Exclusive Partnership with Elite DNA Behavioral Health to Expand NeuroStar Access and Operational Excellence STIM -6.90% GlobeNewswire
Oct-21	Neuronetics to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call STIM +5.49% GlobeNewswire
Sep-17	New York State Medicaid Expands Coverage for TMS Therapy, Including NeuroStar Advanced Therapy, to Treat Major Depressive Disorder (MDD) STIM GlobeNewswire
Aug-06	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) STIM -6.60% STIM -5.65% GlobeNewswire
Aug-05	Neuronetics Reports Second Quarter 2025 Financial and Operating Results STIM GlobeNewswire
Aug-04	Neuronetics to Present at the Canaccord Genuity 45th Annual Growth Conference STIM +5.43% GlobeNewswire
Jul-30	NeuroStar Announces New Publication in JAACAP Open Highlighting Treatment Efficacy in Depressed Adolescents STIM GlobeNewswire
Jul-22	Neuronetics to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call STIM +8.76% GlobeNewswire
Jul-15	Neuronetics Appoints New Chief Financial Officer STIM GlobeNewswire
Jun-19	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) STIM GlobeNewswire
Jun-10	Neuronetics Announces Clinical Presence at the 2025 Clinical TMS Society Annual Meeting and Progress in Greenbrook's Personalized Care Trial Program STIM GlobeNewswire
Jun-02	Neuronetics Set to Join Russell 2000 and Russell 3000 Indexes STIM GlobeNewswire
May-14	Neuronetics Launches First Inaugural National TMS Therapy Awareness Day During Mental Health Awareness Month STIM GlobeNewswire
May-06	Neuronetics Reports First Quarter 2025 Financial and Operating Results STIM GlobeNewswire
May-05	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) STIM GlobeNewswire

Neuronetics

Recent Articles by Neuronetics

Upgrade your Finviz experience